research 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
ITK inhibitors may effectively treat alopecia areata.
Search
forResearch
5 / 420 results
research Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.
research Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.
research Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.
research Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.
Clinics
6 / 21 results- 70
Hair Loss TreatmentsYour Family Medical & Wellness CenterGarden City, MI · US - 21Hair Loss TreatmentsAlaska Family DermatologyAnchorage, AK · US
- 30TrichologyChornyi Family ClinicTernopil · UA
- 9Hair SystemsEverCare Family PracticeSanta Fe, NM · US
- 1Hair Loss TreatmentsRyuo Family ClinicKofu · JP
- 31
Hair Loss TreatmentsWoodinville Family Medicine & Skin ClinicWoodinville, WA · US
Learn
— no results
Community Join
— no results
Experts
— no results